<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35313700</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">1058-9813</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>65</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Progress in pediatric cardiology</Title>
          <ISOAbbreviation>Prog Pediatr Cardiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A comparison of Kawasaki Disease and multisystem inflammatory syndrome in children.</ArticleTitle>
        <Pagination>
          <StartPage>101516</StartPage>
          <MedlinePgn>101516</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ppedcard.2022.101516</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Due to the COVID-19 pandemic a novel disease has emerged, multisystem inflammatory syndrome in children (MIS-C). It presents post virally after a COVID-19 infection, and its clinical presentation and symptoms are very similar to Kawasaki Disease (KD).</AbstractText>
          <AbstractText Label="AIM OF REVIEW" NlmCategory="UNASSIGNED">The objective of this review is to compare and contrast differences of Kawasaki Disease and MIS-C.</AbstractText>
          <AbstractText Label="KEY SCIENTIFIC CONCEPTS OF THE REVIEW" NlmCategory="UNASSIGNED">Kawasaki Disease and MIS-C are very similar in clinical presentation and symptomatology. Understanding the diagnostic criteria is crucial to making an accurate diagnosis. Treatments in Kawasaki Disease are established, while in MIS-C treatment protocols are continuing to develop. Careful history taking and laboratory marker analysis should guide the clinician to accurate diagnosis.</AbstractText>
          <CopyrightInformation>© 2022 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wessels</LastName>
            <ForeName>Philip A</ForeName>
            <Initials>PA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Division of Residency, Nemours Children's Hospital, Orlando, FL, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bingler</LastName>
            <ForeName>Michael A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiovascular Services, Division of Cardiology, Nemours Children's Hospital, Orlando, FL, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Prog Pediatr Cardiol</MedlineTA>
        <NlmUniqueID>9209539</NlmUniqueID>
        <ISSNLinking>1058-9813</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19</Keyword>
        <Keyword MajorTopicYN="N">Kawasaki Disease</Keyword>
        <Keyword MajorTopicYN="N">Multisystem inflammatory syndrome in children</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>22</Day>
          <Hour>5</Hour>
          <Minute>11</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35313700</ArticleId>
        <ArticleId IdType="pmc">PMC8925196</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ppedcard.2022.101516</ArticleId>
        <ArticleId IdType="pii">S1058-9813(22)00036-4</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>About Kawasaki disease. Cdc.gov. May 29, 2020. https://www.cdc.gov/kawasaki/about.html Published.</Citation>
        </Reference>
        <Reference>
          <Citation>Modesti A.M., Plewa M.C.  StatPearls Publishing; 2021. Kawasaki disease.</Citation>
        </Reference>
        <Reference>
          <Citation>McCrindle B.W., Rowley A.H., Newburger J.W., et al.  Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–e999. doi: 10.1161/CIR.0000000000000484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIR.0000000000000484</ArticleId>
            <ArticleId IdType="pubmed">28356445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Payne A.B., Gilani Z., Godfred-Cato S., et al.  Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2. JAMA Netw Open. 2021;4(6) doi: 10.1001/jamanetworkopen.2021.16420.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamanetworkopen.2021.16420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dufort E.M., Koumans E.H., Chow E.J., et al.  Multisystem inflammatory syndrome in children in New York state. N Engl J Med. 2020;383(4):347–358. doi: 10.1056/NEJMoa2021756.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa2021756</ArticleId>
            <ArticleId IdType="pmc">PMC7346766</ArticleId>
            <ArticleId IdType="pubmed">32598830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McMurray J.C., May J.W., Cunningham M.W., Jones O.Y. Multisystem inflammatory syndrome in children (MIS-C), a post-viral myocarditis and systemic vasculitis-a critical review of its pathogenesis and treatment. Front Pediatr. 2020;8 doi: 10.3389/fped.2020.626182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fped.2020.626182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Medscape.org. 2022. https://www.medscape.org/viewarticle/724738 Published. Medscape.org. Accessed January 18, 2022. https://www.medscape.org/viewarticle/724738.</Citation>
        </Reference>
        <Reference>
          <Citation>Chang L.-Y., Lu C.-Y., Shao P.-L., et al.  Viral infections associated with Kawasaki disease. JFormosan MedAssoc. 2014;113(3):148–154. doi: 10.1016/j.Jfma.2013.12.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.Jfma.2013.12.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J.J., Kim H.J., Yu J.J., et al.  IgA levels are associated with coronary artery lesions in Kawasaki disease. Korean Circ J. 2021;51(3):267–278. doi: 10.4070/kcj.2020.0345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4070/kcj.2020.0345</ArticleId>
            <ArticleId IdType="pmc">PMC7925970</ArticleId>
            <ArticleId IdType="pubmed">33655727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yeo W.S., Ng Q.X. Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2. Med Hypotheses. 2020;144(110263) doi: 10.1016/j.mehy.2020.110263.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mehy.2020.110263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grifoni E., Valoriani A., Cei F., et al.  Interleukin-6 as prognosticator in patients with COVID-19. J Infect. 2020;81(3):452–482. doi: 10.1016/j.jinf.2020.06.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jinf.2020.06.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Case Definition | Kawasaki Disease | CDC. www.cdc.gov. October 29, 2018. https://www.cdc.gov/kawasaki/case-definition.html Published.</Citation>
        </Reference>
        <Reference>
          <Citation>CDC . Centers for Disease Control and Prevention; February 11, 2020. Multisystem Inflammatory Syndrome (MIS)https://www.cdc.gov/mis/mis-c/hcp/index.html Published.</Citation>
        </Reference>
        <Reference>
          <Citation>Alsaied T., Tremoulet A.H., Burns J.C., et al.  Review of cardiac involvement in multisystem inflammatory syndrome in children. Circulation. 2021;143(1):78–88. doi: 10.1161/CIRCULATIONAHA.120.049836.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.049836</ArticleId>
            <ArticleId IdType="pubmed">33166178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feldstein L.R., Tenforde M.W., Friedman K.G., et al.  Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA. 2021;325(11):1074–1087. doi: 10.1001/jama.2021.2091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2021.2091</ArticleId>
            <ArticleId IdType="pmc">PMC7905703</ArticleId>
            <ArticleId IdType="pubmed">33625505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rhim J.W., Kang J.H., Lee K.Y. Etiological and pathophysiological enigmas of severe coronavirus disease 2019, multisystem inflammatory syndrome in children, and Kawasaki disease. Clin Exp Pediatr. 2021 doi: 10.3345/cep.2021.01270. Published online.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3345/cep.2021.01270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feldstein L.R., Rose E.B., Horwitz S.M., et al.  Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334–346. doi: 10.1056/NEJMoa2021680.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa2021680</ArticleId>
            <ArticleId IdType="pmc">PMC7346765</ArticleId>
            <ArticleId IdType="pubmed">32598831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Medaglia A.A., Siracusa L., Gioè C., Giordano S., Cascio A., Colomba C. Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature. Ital J Pediatr. 2021;47(1):95. doi: 10.1186/s13052-021-01041-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13052-021-01041-4</ArticleId>
            <ArticleId IdType="pmc">PMC8054252</ArticleId>
            <ArticleId IdType="pubmed">33874991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Godfred-Cato S., Bryant B., Leung J., et al.  COVID-19-associated multisystem inflammatory syndrome in children - United States, March-July 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1074–1080. doi: 10.15585/mmwr.mm6932e2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15585/mmwr.mm6932e2</ArticleId>
            <ArticleId IdType="pmc">PMC7440126</ArticleId>
            <ArticleId IdType="pubmed">32790663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>UpToDate. Uptodate.com. https://www.uptodate.com/contents/covid-19-multisystem-inflammatory-syndrome-in-children-mis-c-clinical-features-evaluation-and-diagnosis?topicRef=129614&amp;source=see_link</Citation>
        </Reference>
        <Reference>
          <Citation>Tremoulet A.H., Jain S., Chandrasekar D., Sun X., Sato Y., Burns J.C. Evolution of laboratory values in patients with Kawasaki disease. Pediatr Infect Dis J. 2011;30(12):1022–1026. doi: 10.1097/INF.0b013e31822d4f56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0b013e31822d4f56</ArticleId>
            <ArticleId IdType="pmc">PMC3222731</ArticleId>
            <ArticleId IdType="pubmed">21817952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henderson L.A., Canna S.W., Friedman K.G., et al.  American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2. Arthritis Rheumatol. 2021;73(4):e13–e29. doi: 10.1002/art.41616.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.41616</ArticleId>
            <ArticleId IdType="pmc">PMC8559788</ArticleId>
            <ArticleId IdType="pubmed">33277976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tse S.M.L., Silverman E.D., McCrindle B.W., Yeung R.S.M. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. J Pediatr. 2002;140(4):450–455. doi: 10.1067/mpd.2002.122469.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1067/mpd.2002.122469</ArticleId>
            <ArticleId IdType="pubmed">12006960</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
